C Kahlert1, M Distler1, D Aust2,3, L Gieldon4, J Weitz1, T Welsch5. 1. Klinik und Poliklinik für Viszeral‑, Thorax- und Gefäßchirurgie (VTG), Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. 2. Institut für Pathologie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland. 3. Tumor- und Normalgewebebank des Universitätskrebszentrums, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Deutschland. 4. Institut für Klinische Genetik, Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Deutschland. 5. Klinik und Poliklinik für Viszeral‑, Thorax- und Gefäßchirurgie (VTG), Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. Thilo.Welsch@uniklinikum-dresden.de.
Abstract
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) represents the fourth most common cause of cancer mortality and it is expected to become the second most common cause of cancer mortality by 2020 in the USA. OBJECTIVE: Which strategies for the detection and treatment of an early stage pancreatic adenocarcinoma and its precursor lesions are to be applied? RESULTS: Currently, there is no effective general screening program for pancreatic cancer due to the low incidence and the lack of an accurate and inexpensive diagnostic method; however, in patients with a positive history of hereditary pancreatic cancer or in patients with a known sporadic germline mutation that is associated with an increased risk of pancreatic cancer, frequent screening is highly recommended to detect and to treat early stage PDAC. Moreover, patients with a precursor lesion for pancreatic cancer (namely a mucinous pancreatic neoplasm) should undergo an oncological pancreatic resection to prevent the development of late stage pancreatic cancer. In future, additional biomarkers from a liquid biopsy, such as circulating tumor cells, exosomes or circulating tumor DNA may improve the early detection of pancreatic cancer. CONCLUSION: The early detection and treatment of pancreatic cancer and its precursor lesions can help to improve the dismal prognosis of this aggressive tumor type.
BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) represents the fourth most common cause of cancer mortality and it is expected to become the second most common cause of cancer mortality by 2020 in the USA. OBJECTIVE: Which strategies for the detection and treatment of an early stage pancreatic adenocarcinoma and its precursor lesions are to be applied? RESULTS: Currently, there is no effective general screening program for pancreatic cancer due to the low incidence and the lack of an accurate and inexpensive diagnostic method; however, in patients with a positive history of hereditary pancreatic cancer or in patients with a known sporadic germline mutation that is associated with an increased risk of pancreatic cancer, frequent screening is highly recommended to detect and to treat early stage PDAC. Moreover, patients with a precursor lesion for pancreatic cancer (namely a mucinous pancreatic neoplasm) should undergo an oncological pancreatic resection to prevent the development of late stage pancreatic cancer. In future, additional biomarkers from a liquid biopsy, such as circulating tumor cells, exosomes or circulating tumor DNA may improve the early detection of pancreatic cancer. CONCLUSION: The early detection and treatment of pancreatic cancer and its precursor lesions can help to improve the dismal prognosis of this aggressive tumor type.
Authors: Jungsun Kim; William R Bamlet; Ann L Oberg; Kari G Chaffee; Greg Donahue; Xing-Jun Cao; Suresh Chari; Benjamin A Garcia; Gloria M Petersen; Kenneth S Zaret Journal: Sci Transl Med Date: 2017-07-12 Impact factor: 17.956
Authors: Chunling Hu; Steven N Hart; William R Bamlet; Raymond M Moore; Kannabiran Nandakumar; Bruce W Eckloff; Yean K Lee; Gloria M Petersen; Robert R McWilliams; Fergus J Couch Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-19 Impact factor: 4.254
Authors: Jeremy L Humphris; Amber L Johns; Skye H Simpson; Mark J Cowley; Marina Pajic; David K Chang; Adnan M Nagrial; Venessa T Chin; Lorraine A Chantrill; Mark Pinese; R Scott Mead; Anthony J Gill; Jaswinder S Samra; James G Kench; Elizabeth A Musgrove; Katherine M Tucker; Allan D Spigelman; Nic Waddell; Sean M Grimmond; Andrew V Biankin Journal: Cancer Date: 2014-10-14 Impact factor: 6.860
Authors: Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz Journal: Sci Transl Med Date: 2014-02-19 Impact factor: 17.956
Authors: Andreas W Berger; Daniel Schwerdel; Ivan G Costa; Thilo Hackert; Oliver Strobel; Sandra Lam; Thomas F Barth; Bernd Schröppel; Alexander Meining; Markus W Büchler; Martin Zenke; Patrick C Hermann; Thomas Seufferlein; Alexander Kleger Journal: Gastroenterology Date: 2016-06-23 Impact factor: 22.682
Authors: Stefano Crippa; Roberto Salvia; Andrew L Warshaw; Ismael Domínguez; Claudio Bassi; Massimo Falconi; Sarah P Thayer; Giuseppe Zamboni; Gregory Y Lauwers; Mari Mino-Kenudson; Paola Capelli; Paolo Pederzoli; Carlos Fernández-del Castillo Journal: Ann Surg Date: 2008-04 Impact factor: 12.969
Authors: Daniel V T Catenacci; Christopher G Chapman; Peng Xu; Ann Koons; Vani J Konda; Uzma D Siddiqui; Irving Waxman Journal: Gastroenterology Date: 2015-09-02 Impact factor: 22.682